News

SOPHiA GENETICS acquires Interactive Biosoftware to drive growth and accelerate Data-Driven Medicine adoption around the world

Milan – Italy, June 16, 2018: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today at the European Human Genetics Conference (ESHG 2018) that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the most used decision support software for clinical genomic [...]

2023-04-03T14:43:15+01:00June 16th, 2018|All News, Company News|

V-Wave Closes $70M Financing to Support Pivotal Study of its Heart Failure Therapy

CAESAREA, Israel, April 26, 2018 /PRNewswire/ — V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF), announced today that it has closed a Series C financing of $70 million led by Deerfield Management [...]

2023-04-06T10:37:41+01:00April 26th, 2018|All News, Company News|

Gynesonics Announces Results from Pivotal IDE Trial for Incision Free Treatment for Uterine Fibroids

Results highlight robust Sonata System design and its potential to become a standard of care for fibroid treatment REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the results from their pivotal IDE trial for the [...]

2023-07-24T17:08:31+01:00January 9th, 2018|All News, Company News|

Endeavour Vision invests in surgical bone repairs specialist Medartis

Endeavour Vision invested in Medartis. Located in Basel, Switzerland, the company develops, manufactures and distributes medical internal fixation devices and surgical instruments offered in system solutions for small bone fractures focusing on the extremities. Medartis was founded in 1997 by Dr. Thomas Straumann. The company launched its first products [...]

2023-07-24T16:54:56+01:00December 21st, 2017|All News, Blog, Company News, Investment|

FLEX Vascular Raises $15 Million Series B Equity Financing

FLEX Vascular Raises $15 Million Series B Equity Financing TOLEDO, Ohio, Aug. 15, 2017 /PRNewswire/ — FLEX Vascular, (or the “Company”) a medical device company developing and commercializing next-generation endovascular products to treat patients suffering from peripheral artery disease (PAD), today announced it had raised $15 million in [...]

2026-11-12T16:49:46+00:00August 15th, 2017|All News, Company News|

Symetis and Boston Scientific reach USD 435 million purchase agreement

Definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment Acquisition of Symetis will expand the treatment offerings for patients with aortic valvular heart disease Acquisition projected to close during the second quarter of 2017, subject to customary closing conditions Symetis’ [...]

2026-11-11T14:15:27+00:00March 30th, 2017|All News, Company News, Previous Sectors|

Vertiflex. Inc. completes $40 million financing round PMA approved Superion demonstrating early commercial success

Vertiflex. Inc. completes $40 million financing round PMA approved Superion® demonstrating early commercial success Carlsbad, CA (March 8, 2017) – Vertiflex, Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, today announced completion of a $40M financing round. New investors, Endeavour Vision and H.I.G. BioHealth [...]

2026-11-12T10:30:19+00:00March 3rd, 2017|All News, Company News|

Gynesonics raises $43 million in equity financing – Endeavour Vision and Abingworth Lead Funding

Redwood City, CA – July 22, 2015 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has raised $43 million in an equity financing. The equity financing was co-led by new investor Endeavour Vision, a technology [...]

2023-06-26T09:31:07+01:00July 22nd, 2015|All News, Company News|

Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo, and Launches Product With First Commercial Implantations

Symetis Joins Industry Leaders Edwards Lifesciences and Medtronic as Only Companies to Offer Both Transapical and Transfemoral Options for Transcatheter Aortic Heart Valve Delivery LAUSANNE, SWITZERLAND–(Marketwired – Sept. 12, 2014) – Symetis SA, the leading European developer of transcatheter aortic valve implantation (TAVI) systems, announced today the launch of [...]

2026-11-12T10:29:46+00:00September 12th, 2014|All News, Company News, Previous Sectors|
Go to Top